PULM
Pulmatrix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.42
+4.41%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-156.9%
Return on equity
-123.6%
Return on assets
-160.8%
Return on invested capital
0.00x
Asset turnover
-$3.9M
Cash from operations
$0.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026